
Marketing Authorization Application for Gadoquatrane Submitted in Japan
Marketing Authorization Application for Gadoquatrane Submitted in Japan Bayer has officially submitted a marketing authorization application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for gadoquatrane, its investigational gadolinium-based contrast agent designed for use in magnetic resonance imaging (MRI).…












